Risk factors and 28 year morbi-mortality of coronary heart disease in a cohort with a low incidence of the disease: The Manresa study;Factores de riesgo y morbi-mortalidad coronaria a los 28 años de seguimiento de una cohorte con baja incidencia de la enfermedad: El estudio de Manresa

Revista Espanola de Salud Publica

Volumn 78, Issue 2, 2004, Pages 229-241

  Tomás Abadal, Luis ^a,b   Varas Lorenzo, Cristina ^a   Pérez, Iñaki ^b   Puig, Teresa ^a   Balaguer Vintró, Ignacio ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Hospital de St Pau   (Spain)

Author keywords

Body mass index; Cholesterol; Cohort studies; Coronary heart disease; Hypertension; Incidence; Ischaemic heart disease; Manresa study; Mortality; Myocardial infarction; Risk factors; Tobacco

Indexed keywords

GLUCOSE;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CASE REPORT; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY RISK; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MALE; MORBIDITY; MORTALITY; RISK FACTOR;

EID: 2442666736     PISSN: 11355727     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1135-57272004000200009     Document Type: Article

References (30)

1. Villar Álvarez F, Banegas Banegas JR, Rodríguez Artalejo F, del Rey Calero J. Mortalidad cardiovascular en España y sus comunidades autónomas (1975-1992). Med Clin (Barc) 1998; 110: 321-7.
2. Tunstall-Pedoe H Kuulasma K, Mähönen M, Tolonen H, Ruokokosky E, Amouyel Ph for the WHO-MONICA Project. Contribution of trends in survival and coronary heart disease mortality: 10-year results from 37 WHO-MONICA Project populationa. Lancet 1999; 353: 1547-57.
3. Sans S, Kesteloot H, Kromhout D on behalf of the Task Force, The burden of cardiovascular disease mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics. Eur Heart J 1997; 18: 1231-48.
4. Keys A, Taylor HL, Blackburn H, Brozek J, Anderson JJ, Simonson E. Coronary heart disease among Minnesota business and professional men followed fifteen years. Circulation 1963; 28: 381-95.
5. Dawber TR, The Framingham Study. The epidemiological atherosclerotic disease. Cambridge MA and London UK: Harvard University Press; 1980.
6. The Pooling Research Group Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chron Dis 1978; 31: 201-71.
7. Keys A, Aravanis C, Blackburn H et al. Seven Countries: A multivariate analysis of death and coronary heart disease. Cambridge, MA and London, UK: Harvard University Press; 1980.
8. Regland DR, Brand RJ. Coronary Heart Disease Mortality in the Western Collaborative Group Study: Follow-up experience of 22 years. Am J Epidemiol 1988; 127: 462-75.
9. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease. Overall findings and differences by age for 316, 099 white men. Arch Intern Med 1992; 152: 56-64.
10. Fraser GE, Straham TM, Sabate J, Beeson WL, Kissinger D. Effects of traditional coronary risk factors on rates of incident coronary events in a low-risk population. The Adventist Health Study. Circulation 1992; 86: 406-13.
11. Chen Z, Peto R, Collin R, MacMahon S, La J, Li W. Serum cholesterol concentration and coronary heart disease in populations with low cholesterol concentrations. BMJ 1991 303: 276-82.
12. Tomás Abadal L, Balaguer Vintró I, Bernades Bernat E. Factores de riesgo e incidencia de nuevos casos en el estudio prospectivo de la cardiopatía isquémica de Manresa. Rev Esp Cardiol 1976;29:127-35.
13. Tomás Abadal L. Estudio prospectivo sobre la cardiopatía coronaria de Manresa:: 15 años de seguimiento. Rev Clin Esp 1887; 180: 4-7.
14. Tomás Abadal L, Varas Lorenzo C, Bernades Bernat E, Balaguer Vintró I. Coronary risk factors and 20-year incidence of coronary heart disease and mortality in a Mediterranean industrial population. The Manresa Study, Spain. Eur Heart J 1994;15: 1028-36.
15. The ERICA Research Group. The CDH risk-map of Europe. The 1st report of the WHO-Erica project. Eur Heart J 1988:9 suppl I:1-36.
16. World Health Organization European Collaborative Group. Multifactorial Trial in the prevention of coronary heart disease: 1. Recruitment and initial findings. Eur Heart J 1980;1:72-80.
17. WHO Monica Project/Keil U and Kuulasma K. WHO MONICA Project: Risk Factors. Int J Epidemiol 1989;18:S46-S55
18. Actualidad Tabaquera Madrid: Servicio de Estudios de Tabacalera 1; 1981.
19. Keys A, Menotti A, Aravanis Ch. The Seven Countries Study: 2.289 death in 15 years. Prev Med 1984;13:141-54.
20. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischaemic heart disease in cross cultural epidemiology. Am J Clin Nutr 1991;53 supl:326S-334S.
21. Renaud S, De Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 1992;339:1523-6.
22. Law M, Wald N. Why heart disease mortality is low in France: the time lag explanation. Br Med J 1999; 318: 1471-80.
23. Pekkanen J, Nissinen A, Puska P, Punsar S, Karvonen MJ. Risk factors and 25 year risk of coronary heart disease in male population with high incidence of the disease: the Finnish cohorts of the Seven Countries Studies BMJ 1989;299:81-5.
24. Haffner SM, D'Agostino R Jr., Mykkanen L, Tracy R, Howard B, Rewers M, Selby J, Savage PJ, Saad MF. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: The insulin resistance Atherosclerosis Study. Diabetes Care, 1999;22:562-8.
25. Calles Escandon J, García Rubí E, Mirza S, Mortensen A. Type 2 diabetes: one disease, multiple cardiovascular risk factors. Coron Artery Dis 1999;10:23-30.
26. Stokes III J, Kannel WB, Wolf PA, The relative importance of selected risk factors for varius manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation 1987; 75: 56V-73V.
27. Colhoun HM, Dong W, Barakat MT, Mather HM, Poulter NR. The scope for cardiovascular disease risk factor intervention among people with diabetes mellitus in England: a population-based analysis from the Health Surveys for England 1991-94. Diabet Med 1999;16:35-40.
28. Orchard TJ, Stevens LK, Forrest KY, Fuller JH. Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe. Int J Epidemiol 1998;27:976-983.
29. López García Aranda V, González López M, Trujillo Berraquero F, Rojas Rodríguez J. Influencia de los factores de riesgo coronario en prevención secundaria: tabaco. Rev Esp Cardiol 1998;51 supp 6:10-7.
30. Mariotti S, Capocaccia R, Farchi G. Age, period, cohort and geographical area effects on the relationship between risk factors and coronary heart disease mortality. 15 year follow-up of the European cohorts of the Seven Countries Study. J Chron Dis 1986;39:229-42.